Oncotelic Therapeutics Partners with TechForce Robotics to Commercialize AI-Driven GMP Robotics Platform

Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biotechnology company focused on oncology and AI-dr...

April 03, 2026 | Friday | News
Thermo Fisher Scientific Launches Automated CTS Compleo System To Streamline Cell Therapy Fill And Finish

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the global launch of the Gibco™ CTS™ Compleo™ Fill ...

April 03, 2026 | Friday | News
Reprogramming the Tumor: Lew Bender on Engineering a New Paradigm in Cancer Therapy

From a basement-born idea to a publicly traded biotech advancing late-stage clinical trials, Lew Bender’s journey reflects both scientific persistenc...

April 02, 2026 | Thursday | Interaction
AskBio Completes Enrollment In GenePHIT Phase 2 Trial For AB 1002 In Heart Failure

Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopath...

April 02, 2026 | Thursday | News
Continuity Biosciences and Breakthrough T1D Partner to Advance NICHE® Cell Therapy Platform Toward First-in-Human Study

Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to...

March 26, 2026 | Thursday | News
Biocytogen and Moonlight Bio Partner to Advance Next-Generation Cell Therapies for Hard-to-Treat Cancers

-Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and devel...

March 25, 2026 | Wednesday | News
Cytiva and SR-TIGET Launch EU’s First Danaher Beacon to Advance Scalable Genomic Medicine

New “Danaher Beacon,” first in the European Union, aims to accelerate translation, scalability, and reliability across cell and gene therap...

March 25, 2026 | Wednesday | News
New England Biolabs Launches EnClose Kit for Rapid Cell-Free dbDNA Synthesis

New England Biolabs announced the release of the EnClose Cell-free dbDNA Synthesis Kit, developed in collaboration with Touchlight. This novel kit enable...

March 23, 2026 | Monday | News
Belief BioMed’s Gene Therapy BBM-H901 Gains Macao Approval for Hemophilia B

Belief BioMed  announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Adminis...

March 23, 2026 | Monday | News
Terumo BCT and Taiwan Bio Collaborate to Automate Treg Therapy Manufacturing Using Quantum Flex Platform

Taiwan Bio will leverage the Quantum Flex™ Cell Expansion System 3-in-1 workflow beyond CAR-T to support&nb...

March 18, 2026 | Wednesday | News
iXCells Delivers 500+ Patient-Derived iPSC Lines, Demonstrating Industrial-Scale Drug Discovery Platform

iXCells Biotechnologies USA, Inc. (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services,  announced the d...

March 16, 2026 | Monday | News
Beyond Cytotoxic Payloads: Redefining the Next Generation of Antibody–Drug Conjugates

As the antibody–drug conjugate (ADC) landscape rapidly evolves, the industry is moving beyond traditional cytotoxic payloads and antibody-first devel...

March 12, 2026 | Thursday | Interaction
iXCells Delivers Over 500 Characterized iPSC Lines Through iPSCore Platform Collaboration

iPSCore platform delivered over 500 characterized iPSC lines during first year of collaboration iXCells Biotechnologies USA, Inc. (“iXCe...

March 12, 2026 | Thursday | News
GenSight Biologics Advances Early Access Programs for LUMEVOQ Gene Therapy in Rare Vision Disorder

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene...

March 10, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close